Heart Institute, Hadassah University Hospital, Jerusalem, Israel.
PLoS One. 2012;7(7):e41022. doi: 10.1371/journal.pone.0041022. Epub 2012 Jul 19.
Patients with heart failure (HF) have a poor prognosis. The proportion of patients with HF and preserved left ventricular function (LVF) is increasing. Long term prognosis of HF with preserved LVF may not be so benign.
To evaluate the long term clinical outcome of patients with HF and preserved LVF and predictors of outcome.
We prospectively evaluated 309 patients hospitalized with a definite clinical diagnosis of HF. Patients were followed for a mean of 6.5 years for clinical outcome.
More than a third (36%) of the patients had preserved systolic LVF based on echocardiography. The long term survival rate in this group was poor and not significantly different from patients with reduced LVF (28% vs 23% respectively, P=0.2). The adjusted survival rate by Cox regression analysis was also not significantly different (hazard ratio 1.16, 95% confidence interval 0.87-1.55, P=0.31). The event free survival from death or heart failure re-hospitalization was also low in both groups and not significantly different between patients with preserved vs. reduced LVF (12% vs. 10% respectively, P=0.2). Predictors of mortality in patients with preserved LVF were age, functional capacity and serum urea levels.
The long term clinical outcome of patients with heart failure and preserved LVF is poor and not significantly different from patients with reduced LVF.
心力衰竭(HF)患者的预后较差。具有左心室功能保留(LVF)的 HF 患者比例正在增加。具有保留 LVF 的 HF 的长期预后可能并不那么良好。
评估具有保留 LVF 的 HF 患者的长期临床结局和结局预测因素。
我们前瞻性评估了 309 例因明确临床诊断 HF 住院的患者。患者平均随访 6.5 年以评估临床结局。
根据超声心动图,超过三分之一(36%)的患者存在收缩期 LVF 保留。该组的长期生存率较差,与 LVF 降低的患者无显著差异(分别为 28%和 23%,P=0.2)。Cox 回归分析调整后的生存率也无显著差异(风险比 1.16,95%置信区间 0.87-1.55,P=0.31)。两组的死亡率或心力衰竭再住院的无事件生存率均较低,且保留与降低 LVF 的患者之间无显著差异(分别为 12%和 10%,P=0.2)。保留 LVF 的患者的死亡预测因素为年龄、功能能力和血清尿素水平。
具有保留 LVF 的 HF 患者的长期临床结局较差,与 LVF 降低的患者无显著差异。